Suchergebnisse - "Williams, Hywel C"

PubPharm (428)

1

Reliable detection of eczema areas for fully automated assessment of eczema severity from digital camera images

enthalten in: bioRxiv.org | 2024

von Attar, R. | Hurault, G. | Wang, Z. | +7

2

Discontinuation of anti-tumour necrosis factor alpha treatment owing to blood test abnormalities, and cost-effectiveness of alternate blood monitoring strategies

enthalten in: The British journal of dermatology | 2024

von Abhishek, A. | Stevenson, M. | Nakafero, G. | +12

CommentIn: Br J Dermatol. 2023 Dec 13;:. - PMID 38092026

3

How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials : a users' guide

enthalten in: The British journal of dermatology | 2024

von Thomas, K. | Howells, L. | Leshem, Y. | +8

CommentIn: Br J Dermatol. 2024 Jan 10;:. - PMID 38197422

4

Patient and health professional views on risk-stratified monitoring of immune-suppressing treatment in adults with inflammatory diseases

enthalten in: Rheumatology (Oxford, England) | 2024

von Fuller, A. | Hancox, J. | Williams, H. | +9

5

Risk-stratified monitoring for sulfasalazine toxicity : prognostic model development and validation

enthalten in: RMD open | 2024

von Abhishek, A. | Grainge, M. | Card, T. | +8

6

Commentary : A comparative randomized clinical trial evaluating the efficacy and safety of tacrolimus versus hydrocortisone as a topical treatment of atopic dermatitis in children

enthalten in: Frontiers in pharmacology | 2024

von Harvey, J. | Stuart, B. | Williams, H.

CommentOn: Front Pharmacol. 2023 Sep 20;14:1202325. - PMID 37799965

7

Cost-effectiveness of two online interventions supporting self-care for eczema for parents/carers and young people

enthalten in: The European journal of health economics : HEPAC : health economics in prevention and care | 2024

von Sach, T. | Onoja, M. | Clarke, H. | +22

8

Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study) : a randomised, open label, superiority trial

enthalten in: The Lancet. Rheumatology | 2024

von Abhishek, A. | Peckham, N. | Pade, C. | +66

9

Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation

enthalten in: bioRxiv.org | 2023

von Abhishek, A. | Grainge, M. | Card, T. | +8

10

The Harmonising Outcome Measures for Eczema (HOME) implementation roadmap

enthalten in: The British journal of dermatology | 2023

von Leshem, Y. | Simpson, E. | Apfelbacher, C. | +8

CommentIn: Br J Dermatol. 2023 Nov 16;189(6):e109. - PMID 37972132

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[43]